DWM
DYN icon

Darwin Wealth Management’s Dyne Therapeutics DYN Stock Holding History

Darwin Wealth Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.45M Buy
155,270
+408
+0.3% +$7.58K 0.94% 32
2026
Q1 		$2.81M Buy
154,862
+39,595
+34% +$683K 0.87% 35
2025
Q4 		$2.25M Sell
115,267
-58,250
-34% -$1.1M 0.7% 40
2025
Q3 		$2.19M Buy
173,517
+861
+0.5% +$9.82K 0.7% 40
2025
Q2 		$1.64M Buy
172,656
+120,566
+231% +$1.33M 0.57% 51
2025
Q1 		$1.23M Hold
52,090
– – 0.41% 63
2024
Q4 		$1.23M Buy
+52,090
New +$1.54M 0.41% 63

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Darwin Wealth Management's DYN Position: Q2 2026 in Review

Darwin Wealth Management increased its Dyne Therapeutics (DYN) stake by 0.26% in Q2 2026, buying an estimated $7.58K and bringing the position to 155,270 shares worth $3.45M. The position accounts for 0.94% of the portfolio, ranked #32.

Darwin Wealth Management first reported a position in DYN in Q4 2024 and has held it in 7 quarters since. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Darwin Wealth Management held 155,270 shares of Dyne Therapeutics worth $3.45M as of Q2 2026.
  • Darwin Wealth Management bought 408 Dyne Therapeutics shares in Q2 2026, an estimated $7.58K.
  • Dyne Therapeutics made up 0.94% of Darwin Wealth Management's portfolio in Q2 2026, its #32 holding.
  • Darwin Wealth Management first reported a position in Dyne Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.